Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M96,105Revenue $M36,247Net Margin (%)41.2Altman Z-Score2.2
Enterprise Value $M116,234EPS $5.3Operating Margin %47.3Piotroski F-Score6
P/E(ttm)6.7Beneish M-Score-1.7Pre-tax Margin (%)48.2Higher ROA y-yY
Price/Book12.210-y EBITDA Growth Rate %0.5Quick Ratio1.0Cash flow > EarningsN
Price/Sales2.85-y EBITDA Growth Rate %-5.1Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow44.0y-y EBITDA Growth Rate %108ROA % (ttm)19.9Higher Current Ratio y-yY
Dividend Yield %6.1PEG--ROE % (ttm)169Less Shares Outstanding y-yN
Payout Ratio %39.0Shares Outstanding M2,435ROIC % (ttm)56.8Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKKahn Brothers 2015-12-31 Add0.2%$39.1 - $43.53
($40.81)
$ 39.47-3%Add 47.13%84,600
GSKKen Fisher 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 39.47-3%Add 0.03%11,531,673
GSKDodge & Cox 2015-09-30 Reduce-0.46%$37.56 - $45.14
($41.64)
$ 39.47-5%Reduce -98.37%202,915
GSKCharles Brandes 2015-09-30 Add0.2%$37.56 - $45.14
($41.64)
$ 39.47-5%Add 8.33%4,673,082
GSKJohn Rogers 2015-09-30 Add0.12%$37.56 - $45.14
($41.64)
$ 39.47-5%Add 20.07%1,458,162
GSKHOTCHKIS & WILEY 2015-09-30 Add0.12%$37.56 - $45.14
($41.64)
$ 39.47-5%Add 6.76%12,400,884
GSKNWQ Managers 2015-09-30 Reduce-0.03%$37.56 - $45.14
($41.64)
$ 39.47-5%Reduce -9.49%462,055
GSKTweedy Browne 2015-09-30 Add0.01%$37.56 - $45.14
($41.64)
$ 39.47-5%Add 4.03%133,458
GSKJoel Greenblatt 2015-09-30 Reduce-0.01%$37.56 - $45.14
($41.64)
$ 39.47-5%Reduce -35.81%51,451
GSKKahn Brothers 2015-09-30 Reduce$37.56 - $45.14
($41.64)
$ 39.47-5%Reduce -1.20%57,500
GSKKen Fisher 2015-09-30 Reduce$37.56 - $45.14
($41.64)
$ 39.47-5%Reduce -0.05%11,528,069
GSKJames Barrow 2015-09-30 Reduce$37.56 - $45.14
($41.64)
$ 39.47-5%Reduce -1.31%249,000
GSKDodge & Cox 2015-06-30 Reduce-0.47%$41.65 - $48.23
($45.06)
$ 39.47-12%Reduce -46.76%12,476,998
GSKCharles Brandes 2015-06-30 Add0.23%$41.65 - $48.23
($45.06)
$ 39.47-12%Add 11.20%4,313,622
GSKHOTCHKIS & WILEY 2015-06-30 Reduce-0.11%$41.65 - $48.23
($45.06)
$ 39.47-12%Reduce -5.59%11,615,471
GSKJohn Rogers 2015-06-30 Add0.08%$41.65 - $48.23
($45.06)
$ 39.47-12%Add 16.22%1,214,427
GSKKen Fisher 2015-06-30 Add0.06%$41.65 - $48.23
($45.06)
$ 39.47-12%Add 7.22%11,533,371
GSKNWQ Managers 2015-06-30 Add0.03%$41.65 - $48.23
($45.06)
$ 39.47-12%Add 11.86%510,500
GSKJoel Greenblatt 2015-06-30 Reduce$41.65 - $48.23
($45.06)
$ 39.47-12%Reduce -4.09%80,157
GSKJames Barrow 2015-06-30 Reduce$41.65 - $48.23
($45.06)
$ 39.47-12%Reduce -6.87%252,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2277.59view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.1484.82view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29638.56view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12225.58view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14179.07view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12225.58view

Press Releases about GSK :

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    10 Fund Managers Are Totally Wrong on GlaxoSmithKline Jan 26 2016 
    Stocks Bring High Dividend Yields to HOTCHKIS & WILEY Jan 14 2016 
    Jeff Auxier's Holdings Trading Below Peter Lynch Earnings Line Jan 04 2016 
    Cisco Systems, Microsoft and Intel Bring High Dividend Yields to First Eagle Investment Jan 04 2016 
    High Dividend Yield Ratios Are Hallmarks of Many Dodge & Cox Stakes Dec 21 2015 
    John Rogers' Holdings Trading Below Peter Lynch Earnings Line Dec 16 2015 
    3 Global Investment Ideas From Gurus Dec 10 2015 
    Dodge & Cox Sells Most of Stakes in Chevron, GlaxoSmithKline Nov 17 2015 
    3 Investment Ideas of Ariel Investment's Rupal Bhansali Nov 16 2015 
    Pfizer to Create a New Pharmaceutical Colossus Nov 05 2015 

    More From Other Websites
    GlaxoSmithKline Plc Earnings Analysis: 2015 By the Numbers Feb 08 2016
    Top of The List: Largest Biotech/Pharma Companies and Largest CROs Feb 08 2016
    Biogen joins international effort to share preclinical data Feb 08 2016
    Why I’d Buy GlaxoSmithKline plc Over Smith & Nephew plc And Shire PLC Feb 08 2016
    Why I'd Buy GlaxoSmithKline plc Over Smith & Nephew plc And Shire PLC Feb 08 2016
    Sir Philip Hampton to lead campaign for more female executives Feb 07 2016
    Better together, maybe, but the break-up calls continue to plague GSK Feb 06 2016
    Neil Woodford Sells GlaxoSmithKline plc — But Don’t Panic! Feb 05 2016
    Neil Woodford Sells GlaxoSmithKline plc -- But Don't Panic! Feb 05 2016
    Beginners’ Portfolio: GlaxoSmithKline plc Gains Ground, while BP plc And Barclays PLC Are... Feb 05 2016
    Beginners' Portfolio: GlaxoSmithKline plc Gains Ground, while BP plc And Barclays PLC Are Faltering Feb 05 2016
    Questor share tip: AstraZeneca faces Crestor crunch in year ahead Feb 05 2016
    Glaxo Tops Q4 Earnings, Revenues Rise Y/Y, 2016 View Intact Feb 04 2016
    Why GlaxoSmithKline plc, Aviva plc & Trifast plc Are Beaming Bargains! Feb 04 2016
    Why GlaxoSmithKline plc, Aviva plc & Trifast plc Are Beaming Bargains! Feb 04 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK